Stock KNE KANE BIOTECH INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Kane Biotech Inc Toronto S.E.

Equities

KNE

CA4838092084

Biotechnology & Medical Research

Business Summary

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

Sales per Business

CAD in Million2022Weight2023Weight Delta
All Other
100.0 %
0 5.9 % 0 100.0 % -4.95%

Sales per region

CAD in Million2022Weight2023Weight Delta
International
93.1 %
1 55.5 % 0 93.1 % -90.63%
Canada
6.9 %
1 44.5 % 0 6.9 % -99.13%

Managers

Managers TitleAgeSince
Marc Edwards CEO
 Chief Executive Officer - 16-06-01
Ray Dupuis DFI
 Director of Finance/CFO - 17-09-04
Lori Christofalos CMP
 Compliance Officer - 19-08-11
Gregory Schultz CTO
 Chief Tech/Sci/R&D Officer 73 22-04-04
John Coleman BRD
 Director/Board Member - Nov. 15
Wendy Nachtigall SAM
 Sales & Marketing - 15-09-30

Members of the board

Members of the board TitleAgeSince
R. Renaud BRD
 Director/Board Member - 10-09-14
Robert B. Huizinga CHM
 Chairman 59 Feb. 19
Georges Morin BRD
 Director/Board Member - 20-05-19
Marc Edwards CEO
 Chief Executive Officer - 16-06-01
John Coleman BRD
 Director/Board Member - Nov. 15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 131,844,567 85,786,381 ( 65.07 %) 0 65.07 %

Shareholders

NameEquities%Valuation
R. Renaud
19.26 %
25,389,711 19.26 % 2 M $
Richard Renaud
11.10 %
14,630,333 11.10 % 1 M $
Marc Edwards
4.466 %
5,888,142 4.466 % 423 946 $
Ray Dupuis
0.7474 %
985,404 0.7474 % 70 949 $
Georges Morin
0.1138 %
150,000 0.1138 % 10 800 $

Company contact information

Kane Biotech, Inc.

100 Innovation Drive Suite 290

R3T 6G2, Winnipeg

+

http://www.kanebiotech.com
address Kane Biotech Inc(KNE)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. KNE Stock
  4. KNE Stock
  5. Company Kane Biotech Inc